Oncology Drugs Advisory Committee Meetings FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - Oncology Drugs Advisory Committee Meetings List of Tentative Meeting Dates for All CDER Advisory Committees List of Committee Members Committee Charter CDER Contacts Current Year Meeting Information 2004 FDA Advisory Committee Calendar -Meeting information includes center, date, time and...
http://www.fda.gov/cder/orange/appendix_a.txt 400, ERYTHROMYCIN ETHYLSUCCINATE E.E.S., ERYTHROMYCIN ETHYLSUCCINATE EC-NAPROSYN, NAPROXEN ECONAZOLE NITRATE, ECONAZOLE NITRATE ECONOCHLOR, CHLORAMPHENICOL ECONOPRED PLUS, PREDNISOLONE ACETATE ECONOPRED, PREDNISOLONE ACETATE EDECRIN, ETHACRYNATE SODIUM EDECRIN, ETHACRYNIC ACID EDETATE DISODIUM, EDETATE DISODIUM EDEX, ALPROSTADIL EDROPHONIUM CHLORIDE PRESERVATIVE FREE, EDROPHONIUM...
OGD Suitability Tracking Reports (Sorted by Petition Number) as of 1/5/2004 - TABLET; ORAL Approved 2/28/2003- BACLOFEN 10 mg, 20 mg - 02P-0078/CP1 KLEINFELD, KAPLAN & BECKER - ORALLY DISINTEGRATING TABLETS Approved 2/5/2003- OXYCODONE 5mg, 7.5mg, 10mg ACETAMINOPHEN 300mg - 02P-0105/CP1 LACHMAN CONSULTANT SERVICES - TABLETS Approved 8/6/2002- CARISOPRODOL 350 mg - 02P-0138/CP1 LACHMAN CONSULTANT SERVICES - ORALLY DISINTEGRATING TABLETS Withdrawn 7/25/2002-...
OGD Suitability Tracking Reports (Sorted by Drug Name) as of 1/5/2004 - CAPSULE; ORAL Approved 8/2/2001- EPIRUBICIN HYDROCHLORIDE 10mg/ 5mL;150mg/75mL - 03P-0110/CP1 FAULDING PHARMACEUTICAL COHYDROCHLORIDE 1 MG - 02P-0424/CP1 BANNER PHARMACAPS - CAPSULE; ORAL Approved 4/14/2003- LOPERAMIDE HYDROCHLORIDE 2 mg - 02P-0380/CP1 BANNER PHARMACAPS - SOFT GELATIN CAPSULES Pending -...
Prescription and Over-the-Counter Drug Product List: 11/2003 ACTHAR GEL >D> BC + QUESTCOR PHARMS 80 UNITS/ML N08372 008 NOV CTEC >A> + 80 UNITS/ML N08372 008 NOV CTEC CYTARABINE INJECTABLE; INJECTION >D> CYTARABINE >D> AP + GENSIA SICOR PHARMS 100MG/VIAL N16793 001 NOV DISC >D> AP + 500MG/VIAL N16793 002 NOV DISC >D> AP + 1GM/VIAL N16793 003 DEC 21, 1987 NOV DISC >D> AP + 2GM/VIAL N16793 004 DEC 21, 1987 NOV DISC >A> @ SICOR PHARMS 100MG/VIAL...
../99/50-778_Ellence_ Food and Drug Administration • Center for Drug Evaluation and Research Title Search Ellence (Epirubicin Hydrochloride) Injection Company:--Pharmacia & Upjohn Company Application No.:--50-778 Approval Date:-9/15/1999 Approval Letter(s) - Printed Labeling - Medical Review(s) Part 1 - Part 2 - Part 3 - Part 4 - Part 5 - Chemistry Review(s) - Pharmacology Review(s) -...
author: USERNAME
Selected Publications (First Author) RYOICHI NAGATA, M.D., Ph.D
Prescription and OTC Drug Product List 9/1999 Prescription and Over-the-Counter Drug Product List - 19th Edition Cumulative Supplement Number 9: September 1999 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE ATENOLOL CAPSULE; ORAL TABLET; ORAL - DLT - BUTALBITAL, ACETAMINOPHEN, CAFFEINE ATENOLOL - DLT - AB GRAHAM DM 325MG;50MG;40MG N88758 001 - ADD - MYLAN 25MG...
FDA Drug Approvals List August 1999 Drug Approvals for September 1999 Definitions and Notes Original New Drug Applications Original Application #: 021079 Approval Date: 24-SEP-99 Trade Name:ALAMAST Chemical Type: 1 Therapeutic Potential: P Dosage Form: SOLUTION Applicant: SANTEN INC Active Ingredient(s): PEMIROLAST POTASSIUM OTC/RX Status: RX Indication(s): For the prevention of itching of the eye due to allergic...
Bioniche February 12, 2008 Bioniche Reports Fiscal 2008 Second Quarter February 8, 2008 Bioniche Receives $5 Million Capital Financing Support to Scale-up E.
Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
Breast Cancer, Cancers, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - SECTION 3 Medical Conditions CHAPTER 51 - Cancers TOPICS - Introduction -~ Breast Cancer-~ Chronic Lymphocytic Leukemia -~ Colorectal Cancer -~ Lung Cancer -~ Mouth,...
Cancer: Breast Disorders: Merck Manual Home Edition Section Women's Health Issues Subject Breast Disorders Cancer Breast cancer is the second most common cancer among women after skin cancer and, of cancers, is the second most common cause of death among women after lung cancer.
Cancer: Breast Disorders: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
THE MERCK MANUAL OF GERIATRICS, Index E - Index Index-A -| Index-B -| Index-C -| Index-D -| Index-E -| Index-F -| Index-G -| Index-H -| Index-I -| Index-J &n; bsp;| Index-K -| Index-L -| Index-M -| Index-N -| Index-O -| Index-P -| Index-Q -| Index-R -| Index-S -| Index-T -| Index-U -| Index-V -| Index-W -| Index-X,Y,Z Index E Eagle's syndrome 1350 Earache 133 3-1334 Ears (see also Hearing ) acoustic neuroma of 1341-1342...
YM BioSciences Inc. Press Releases 04 Nov, 2003 YM BioSciences Cleared by FDA to Initiate Phase III Registrational Trial for Breast Cancer Drug MISSISSAUGA, Canada a€“ November 04, 2003 a€“ YM BioSciences Inc.
YM BioSciences Inc. Press Releases 31 Mar, 2004 YM BIOSCIENCES DOSES FIRST PATIENT IN PIVOTAL BREAST CANCER STUDY MISSISSAUGA , Canada a€“ March 31, 2004 a€“ YM BioSciences Inc.
YM BioSciences Inc. Press Releases 05 May, 2004 Frost & Sullivan Names YM BioSciences 2004 Breast Cancer Therapies Entrepreneur Palo Alto, Calif.
YM BioSciences Inc. Press Releases 19 May, 2005 YM BioSciences survival analysis data published at ASCO MISSISSAUGA, ON, May 19 - YM BioSciences Inc.
YM Bioscience Inc. 17 Nov, 2005 YM BIOSCIENCES EXPANDS DEVELOPMENT AND COMMERCIALIZATION PROGRAM FOR EGFR INHIBITOR NIMOTUZUMAB 14 Nov, 2005 YM BIOSCIENCES REPORTS FIRST QUARTER 2006 OPERATIONAL AND FINANCIAL RESULTS 13 Oct, 2005 POSITIVE PHASE II PROSTATE CANCER RESULTS WITH YM BIOSCIENCESa€™ LEAD CANCER DRUG TESMILIFENE PUBLISHED IN JOURNAL OF UROLOGY - Read the abstract on tesmilifene...
author: Jeremy Oudit for the Equicom Group Inc. 2002
Wyeth: News & Announcements Back to my archive search Start a new archive search 09/24/2004 Genentech and Wyeth Announce Manufacturing Agreement SOUTH SAN FRANCISCO, CA and COLLEGEVILLE, PA a€“ September 23, 2004 a€“ Genentech, Inc.
Sarcoma, soft tissue, adult: Treatment - Health Professional Information [NCI PDQ] - Quest Diagnostics Patient Health Library Sarcoma, soft tissue, adult: Treatment - Health Professional Information [NCI PDQ] This information is produced and provided by the National Cancer Institute (NCI).
Ovarian epithelial cancer: Treatment - Health Professional Information [NCI PDQ] - Quest Diagnostics Patient Health Library Ovarian epithelial cancer: Treatment - Health Professional Information [NCI PDQ] This information is produced and provided by the National Cancer Institute (NCI).
Nasopharyngeal cancer: Treatment - Health Professional Information [NCI PDQ] - Quest Diagnostics Patient Health Library Two randomized prospective trials compared combination chemotherapy (cisplatin, epirubicin, and bleomycin or cisplatin plus fluorouracil [5-FU] infusion) plus radiation therapy to radiation therapy alone.[ 1 ][Level of evidence: 1iiA];[ 10 ][Level of evidence: 1iiDi] Although disease-free survival was improved in the chemotherapy group for both groups, improvement in overall...
